HURA
TuHURA Biosciences Inc
NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY
$2.40
-10.27% today
Updated 2026-06-05
Market cap
$125.14M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$0 – $4
Volume
0.9M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-8.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$8.04
+235.00%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -8.20 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-4.46M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-22.66M | $-14.65M | $-8.32M | $-21.68M | $-7.54M |
| EPS | — | — | — | — | $-0.61 |
| Free cash flow | $-6.57M | $-7.74M | $-7.26M | $-14.79M | $-4.46M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
TuHURA Biosciences Inc trades at $2.40. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -8.20, it sits in the distress.
Frequently asked questions
What is TuHURA Biosciences Inc's stock price?
TuHURA Biosciences Inc (HURA) trades at $2.40.
Is TuHURA Biosciences Inc overvalued?
TuHURA Biosciences Inc carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of TuHURA Biosciences Inc (HURA)?
The 12-month analyst consensus target is $8.04, about 235.0% above the current $2.40. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
TuHURA Biosciences Inc's Altman Z-Score is -8.20, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-133.39%
Beta—
50D MA$2.29
200D MA$1.91
Shares out0.06B
Float0.04B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—